{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T15:09:01Z","timestamp":1794236941642,"version":"4.9.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.canlet.2024.216921","type":"journal-article","created":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T01:57:47Z","timestamp":1714787867000},"page":"216921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Bmi1 facilitates the progression of cholangiocarcinoma by inhibiting Foxn2 expression dependent on a histone H2A ubiquitination manner"],"prefix":"10.1016","volume":"592","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1886-8782","authenticated-orcid":false,"given":"Yan","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huikang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anda","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhuang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2024.216921_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.canlet.2024.216921_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma - evolving concepts and therapeutic strategies","volume":"15","author":"Rizvi","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2024.216921_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/HEP.0000000000000437","article-title":"Bile exosomal miR-182\/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation","volume":"79","author":"Shu","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2024.216921_bib4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2024.216921_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5009\/gnl15568","article-title":"Cholangiocarcinoma: current Knowledge and new developments","volume":"11","author":"Blechacz","year":"2017","journal-title":"Gut Liver"},{"key":"10.1016\/j.canlet.2024.216921_bib6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2024.216921_bib7","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41576-022-00499-0","article-title":"Context-specific Polycomb mechanisms in development","volume":"23","author":"Kim","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.canlet.2024.216921_bib8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41580-021-00341-1","article-title":"The roles of Polycomb repressive complexes in mammalian development and cancer","volume":"22","author":"Piunti","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2024.216921_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nature08040","article-title":"Bmi1 regulates mitochondrial function and the DNA damage response pathway","volume":"459","author":"Liu","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2024.216921_bib10","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.molcel.2005.12.002","article-title":"Role of bmi-1 and Ring1A in H2A ubiquitylation and hox gene silencing","volume":"20","author":"Cao","year":"2005","journal-title":"Mol. Cell."},{"key":"10.1016\/j.canlet.2024.216921_bib11","first-page":"3161","article-title":"bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis","volume":"8","author":"Haupt","year":"1993","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2024.216921_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.canlet.2003.07.009","article-title":"The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a\/p14ARF proteins","volume":"203","author":"Kim","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216921_bib13","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1158\/0008-5472.CAN-06-0094","article-title":"Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells","volume":"66","author":"Song","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.216921_bib14","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/jcb.26353","article-title":"Loss of BMI-1 dampens migration and EMT of colorectal cancer in inflammatory microenvironment through TLR4\/MD-2\/MyD88-mediated NF-kappaB signaling","volume":"119","author":"Ye","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2024.216921_bib15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.stem.2020.06.022","article-title":"BMI1 inhibition eliminates residual cancer stem cells after PD1 blockade and activates antitumor immunity to prevent metastasis and relapse","volume":"27","author":"Jia","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2024.216921_bib16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/15548627.2016.1147670","article-title":"Inhibition of BMI1 induces autophagy-mediated necroptosis","volume":"12","author":"Dey","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2024.216921_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105365","article-title":"Bmi1 drives the formation and development of intrahepatic cholangiocarcinoma independent of Ink4A\/Arf repression","volume":"164","author":"Guo","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2024.216921_bib18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00018-022-04500-1","article-title":"BMI1 promotes cholangiocarcinoma progression and correlates with antitumor immunity in an exosome-dependent manner","volume":"79","author":"Liu","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2024.216921_bib19","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1242\/dev.058396","article-title":"The control of foxN2\/3 expression in sea urchin embryos and its function in the skeletogenic gene regulatory network","volume":"138","author":"Rho","year":"2011","journal-title":"Development"},{"key":"10.1016\/j.canlet.2024.216921_bib20","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/s41418-017-0055-6","article-title":"beta-Trcp ubiquitin ligase and RSK2 kinase-mediated degradation of FOXN2 promotes tumorigenesis and radioresistance in lung cancer","volume":"25","author":"Ma","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2024.216921_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010009","article-title":"HOXC6-Mediated miR-188-5p expression induces cell migration through the inhibition of the tumor suppressor FOXN2","volume":"23","author":"Jeong","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2024.216921_bib22","first-page":"731","article-title":"FOXN2 suppresses the proliferation and invasion of human hepatocellular carcinoma cells","volume":"25","author":"Liu","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2024.216921_bib23","first-page":"486","article-title":"Long non-coding RNA WT1-AS inhibits cell aggressiveness via miR-203a-5p\/FOXN2 axis and is associated with prognosis in cervical cancer","volume":"23","author":"Dai","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2024.216921_bib24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2147\/CMAR.S176938","article-title":"FOXN2 is downregulated in breast cancer and regulates migration, invasion, and epithelial- mesenchymal transition through regulation of SLUG","volume":"11","author":"Ye","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.canlet.2024.216921_bib25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrm4067","article-title":"Targeting Polycomb systems to regulate gene expression: modifications to a complex story","volume":"16","author":"Blackledge","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2024.216921_bib26","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/nar\/gkl119","article-title":"BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas","volume":"34","author":"Nowak","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2024.216921_bib27","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1182\/blood-2010-02-270660","article-title":"BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells","volume":"116","author":"Rizo","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2024.216921_bib28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13046-021-01980-0","article-title":"TRIM37 orchestrates renal cell carcinoma progression via histone H2A ubiquitination-dependent manner","volume":"40","author":"Miao","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.216921_bib29","first-page":"219","article-title":"Effects of lipid based Multiple Micronutrients Supplement on the birth outcome of underweight pre-eclamptic women: a randomized clinical trial","volume":"38","author":"Mohammad","year":"2022","journal-title":"Pakistan J. Med. Sci."},{"key":"10.1016\/j.canlet.2024.216921_bib30","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41571-023-00770-1","article-title":"Cholangiocarcinoma - novel biological insights and therapeutic strategies","volume":"20","author":"Ilyas","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2024.216921_bib31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3322\/caac.21779","article-title":"Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma","volume":"73","author":"Ruff","year":"2023","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.canlet.2024.216921_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107517","article-title":"The choice for the optimal therapy in advanced biliary tract cancers: chemotherapy, targeted therapies or immunotherapy","volume":"210","author":"Palmieri","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2024.216921_bib33","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1200\/JCO.2009.27.4787","article-title":"Genetics of biliary tract cancers and emerging targeted therapies","volume":"28","author":"Hezel","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2024.216921_bib34","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jhep.2020.03.007","article-title":"Molecular targeted therapies: ready for \"prime time\" in biliary tract cancer","volume":"73","author":"Lamarca","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2024.216921_bib35","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/stem.1035","article-title":"Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences","volume":"30","author":"Siddique","year":"2012","journal-title":"Stem Cell."},{"key":"10.1016\/j.canlet.2024.216921_bib36","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1038\/s41467-023-42930-y","article-title":"Cathepsin-facilitated invasion of BMI1-high hepatocellular carcinoma cells drives bile duct tumor thrombi formation","volume":"14","author":"Xu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.216921_bib37","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1053\/j.gastro.2007.06.016","article-title":"Enhanced self-renewal capability in hepatic stem\/progenitor cells drives cancer initiation","volume":"133","author":"Chiba","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2024.216921_bib38","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.humpath.2009.01.027","article-title":"Polycomb group protein Bmi1 is overexpressed and essential in anchorage-independent colony formation, cell proliferation and repression of cellular senescence in cholangiocarcinoma: tissue and culture studies","volume":"40","author":"Sasaki","year":"2009","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.canlet.2024.216921_bib39","doi-asserted-by":"crossref","first-page":"22947","DOI":"10.1002\/jcp.28856","article-title":"LncRNA-MEG3 inhibits cell proliferation and invasion by modulating Bmi1\/RNF2 in cholangiocarcinoma","volume":"234","author":"Li","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2024.216921_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"Consortium","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2024.216921_bib41","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1101\/gad.1742609","article-title":"Bmi-1 regulates the Ink4a\/Arf locus to control pancreatic beta-cell proliferation","volume":"23","author":"Dhawan","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2024.216921_bib42","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/16476","article-title":"The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus","volume":"397","author":"Jacobs","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2024.216921_bib43","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41419-021-03748-y","article-title":"BMI1 regulates multiple myeloma-associated macrophage's pro-myeloma functions","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2024.216921_bib44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41419-022-04538-w","article-title":"BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells","volume":"13","author":"Azzoni","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2024.216921_bib45","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/cpdd.904","article-title":"Pharmacokinetics and safety of PTC596, a novel tubulin-binding agent, in subjects with advanced solid tumors","volume":"10","author":"Shapiro","year":"2021","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.canlet.2024.216921_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008104","article-title":"The E3 ubiquitin-ligase Bmi1\/Ring1A controls the proteasomal degradation of Top2alpha cleavage complex - a potentially new drug target","volume":"4","author":"Alchanati","year":"2009","journal-title":"PLoS One"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524003148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524003148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T21:10:15Z","timestamp":1716412215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524003148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":46,"alternative-id":["S0304383524003148"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216921","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bmi1 facilitates the progression of cholangiocarcinoma by inhibiting Foxn2 expression dependent on a histone H2A ubiquitination manner","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216921","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"216921"}}